NEW YORK (GenomeWeb News) – Evotec has agreed to provide Biogen Idec with high-throughput screening and assay development services for a particular target, Evotec said today.

Evotec said that it will use its protein production, assay development, and screening technologies to identify drug candidates for Biogen Idec. The agreement also includes an option to cover further targets.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Polygamy amplified a rare genetic disease in area near Arizona-Utah border, BBC Future reports.

Genetic ancestry testing led one woman to learn that her father and another baby boy had been switched at birth, the Washington Post reports.

Simple de-identification methods can protect information in a database from attackers, a new study suggests.

In Science this week: approach to visualize chromatin structure in nuclei, and more.